AstraZeneca’s CARES phase III clinical programme of anselamimab in light chain amyloidosis fails to meet primary endpoint: Cambridge, UK Thursday, July 17, 2025, 09:00 Hrs [IST] ...

Shardul Nautiyal, Mumbai Thursday, July 17, 2025, 08:00 Hrs [IST] ...

Centre extends deadline for online submission of WHO-GMP COPP applications till August 15: Gireesh Babu, New Delhi Thursday, July 17, 2025, 08:00 Hrs [IST] The Drugs Controller Ge ...

IISc & Tufts University to combat malnutrition & advance metabolic health research with AI & biosensors: Nandita Vijayasimha, Bengaluru Thursday, July 17, 2025, 08:00 Hrs [IST] Th ...

FIPO Kerala demands immediate removal of PCI president amid bribery allegations: Peethaambaran Kunnathoor, Chennai Thursday, July 17, 2025, 08:00 Hrs [IST] The Kerala state commit ...

Exports of drugs and pharmaceuticals from the country registered around 5.2 per cent growth in the first three months of the fiscal year, from April to June, 2025, while imports reported a growth of 4 ...

Reckitt focus on health and hygiene initiatives helps winning Global Health Awards 2025 at House of Commons, London: Our ...

Genomill Health’s Bridge Capture technology detects key mutations from blood samples in metastatic colorectal cancer patients: Turku, Finland Wednesday, July 16, 2025, 18:00 Hrs ...

Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...

Imugene announces phase 1b trial evaluating azer-cel in patients with relapsed/refractory diffuse large B-cell lymphoma: Sydney Wednesday, July 16, 2025, 15:30 Hrs [IST] Imugene L ...

GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk: London, UK Wednesday, July 16, 2025, 14:00 Hrs [IST] GSK ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...